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Abstract 
 
Mutations in the DJ-1 gene cause autosomal recessive, early-onset Parkinsonism. The DJ-1 
protein exerts a protective role against oxidative stress damage, working as a cellular oxidative 
stress sensor, and it seems to regulate gene expression at different levels. In Drosophila, two 
DJ-1 orthologs have been identified: DJ-1α and DJ-1β. Several studies have shown that loss of 
DJ-1β function causes Parkinson’s disease (PD)-like phenotypes in flies such as age-dependent 
locomotor defects, reduced lifespan, and enhanced sensitivity to toxins that induce oxidative 
stress, like the herbicide paraquat. However, no dopaminergic neurodegeneration is observed. 
These results suggested that both locomotor and lifespan phenotypes could be either related to 
defects in oxidative stress response, or in dopaminergic physiology as proposed in mice models. 
In this study, we have employed pharmacological approaches to modify the lifespan phenotype 
of DJ-1β mutant flies. We have assessed the effects of chronic treatments with antiparkinsonian 
drugs as well as with antioxidant compounds on such phenotype finding that only antioxidants 
show statistically significant beneficial effects on DJ-1β mutants’ lifespan. These results 
strongly suggest that oxidative stress plays a causal role in the lifespan phenotype of DJ-1β 
mutants. Consistent with this, we find that loss of DJ-1β function results in cellular 
accumulation of reactive oxygen species (ROS) in adult brains, elevated levels of lipid 
peroxidation and an increased catalase enzymatic activity, thus indicating the existence of high 
oxidative stress levels in DJ-1β mutants and confirming the essential function of the DJ-1β 
protein in protecting the organism against oxidative insults. Our study further shows that the 
lifespan phenotype of DJ-1β mutant flies is amenable to pharmacological intervention , and 
validates Drosophila as a valuable model for testing and identifying new drugs with therapeutic 
potential for PD. 
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1. Introduction 
 
Parkinson’s disease (PD) is the second most common neurodegenerative disorder. Although 
most PD cases are sporadic, several genes are associated with familial disease providing 
important insights into PD pathogenesis (Schultz, 2008). One of them is PARK7 whose 
mutations cause autosomal recessive, early-onset Parkinsonism (Bonifati et al., 2003). PARK7 
(or DJ-1) encodes DJ-1, a small protein that was originally identified as an oncogenic factor 
(Nagakubo et al., 1997). However, studies in cell culture and animal models have demonstrated 
that the DJ-1 protein exerts a protective role against oxidative stress damage, being modified in 
several cysteine residues under these conditions (Canet-Aviles et al., 2004; Betarbet et al., 2006; 
Choi et al., 2006; Meulener et al., 2006). This modification increases with age and exposure to 
oxidative toxins, probably leading to DJ-1 inactivation and eventually predisposing 
dopaminergic (DA) neurons to stress-induced degeneration. Although the molecular function of 
DJ-1 is unclear, it seems that it can regulate gene expression either at the transcriptional or 
translational level and, interestingly, both functions are impaired by oxidation (van der Brug et 
al., 2008; Zhong and Xu, 2008; Blackington et al. 2009). It has been proposed a model whereby 
DJ-1 interacts with mRNAs and dissociates under conditions of oxidative stress, thus the 
apparent pleiotropic effects of DJ-1 may be related to the single function of binding to multiple 
transcripts (van der Brug et al., 2008). 
In Drosophila, two DJ-1 orthologs have been identified, DJ-1α and DJ-1β. Loss of function 
of these genes cause defects in oxidative stress response and locomotion as well as shortened 
lifespan, but only inactivation of DJ-1α expression via RNAi results in DA neurodegeneration 
(Meulener et al., 2005; Menzies et al., 2005; Park et al., 2005; Yang et al., 2005a; Lavara-
Culebras and Paricio, 2007). DJ-1βA286 mutant flies were characterized in our laboratory and 
contain a transposable element insertion in the DJ-1β gene, thus encoding a truncated and 
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probably inactive DJ-1β protein. Despite this, they are viable and fertile but show motor 
impairments and a significantly shorter lifespan than wild-type flies. Moreover, they are highly 
sensitive to paraquat exposure (Lavara-Culebras and Paricio, 2007). Since loss of DJ-1β 
function does not affect DA neuron survival (Menzies et al., 2005; Meulener et al., 2005; Park 
et al., 2005; Lavara-Culebras and Paricio, 2007), one possibility is that the observed motor and 
lifespan phenotypes are due to defects in dopamine neurotransmission or DA neuron 
malfunction, as suggested in mice models (Chen et al., 2005; Goldberg et al., 2005). 
Alternatively, they could be caused by oxidative damage. Supporting this, it was previously 
shown that age-dependent locomotor defects exhibited by DJ-1β mutants carrying a different 
allele were substantially enhanced by paraquat treatment (Park et al., 2005). Furthermore, a 
recent study has shown that two compounds with antioxidant and anti-inflammatory properties 
partially suppress DA neuron loss and locomotor dysfunction of DJ-1α RNAi flies (Faust et al., 
2009). In such a scenario, we have investigated the molecular mechanisms involved in the 
lifespan phenotype of DJ-1βA286 mutant flies, by testing the effects on this phenotype of several 
compounds that were added to the flies’ diet. In this study, DJ-1β mutant flies were chronically 
treated with representatives of the major classes of drugs used to mitigate the effects of 
dopaminergic neuron loss in PD patients, like L-DOPA or pergolide, and the experimental 
compound SK&F 38393, as well as with compounds that exhibit antioxidant activity, including 
vitamin C, melatonin or α-tocopherol. We find that lifespan of DJ-1βA286 mutants is 
significantly extended after chronic treatments with antioxidant agents but it is unaffected by 
exposure to antiparkinsonian drugs. Although lifespan values are not restored to wild-type in the 
DJ-1β mutant flies, our results indicate that the lifespan phenotype is mediated, at least in part, 
by oxidative damage and not by defects in DA neuron physiology as previously suggested 
(Lavara-Culebras and Paricio, 2007). Confirming these results, we have observed an increase in 
several markers of oxidative stress in DJ-1βA286 mutants when compared to control flies. 
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2. Materials and methods 
 
2.1. Drosophila stocks and drug feeding 
 
The stocks used in this study (y
1
 w
1118
; PBac{5HPw
+
}DJ-1βA286 and y1, w1118) were obtained 
from the Bloomington Stock Center. Flies were cultured on standard food supplemented with 
antiparkinsonian drugs like L-DOPA, SK&F 38393 and pergolide, or with the antioxidant 
compounds α-tocopherol and melatonin (purchased from Sigma) at a final concentration of 1 
mM, unless otherwise stated. In non-treatment control experiments, flies were fed standard food 
containing the corresponding solvents recommended by the suppliers for each compound. 
Ascorbic acid (0.25 mg/ml) was also added to food containing L-DOPA and SK&F 38393 to 
prevent drug oxidation. In both cases, standard food containing 0.25 mg/ml of ascorbic acid was 
used as non-treatment control. L-DOPA treatment was also performed by using butylated 
hydroxytoluene (BHT) as antioxidant, and standard food containing 1 mM BHT was used as 
non-treatment control in this case. Drug and control feeding trials were carried out at 25ºC from 
day 1-2 after eclosion through adulthood in standard vials containing 1.5 or 2 ml of medium. 
 
2.2 Lifespan assays 
 
Cohorts of 200 1-2-day-old DJ-1βA286 mutants or y, w control flies were collected and tested 
for each drug. Flies were separated by sex and divided in groups of 25 individuals. Those 
groups were put into vials with control or supplemented food. Every second or third day, flies 
were transferred to new vials and the number of dead flies in each vial was scored. This process 
was followed until all flies died, and the percentage of flies alive at each time point was graphed 
(Greene et al., 2003). The results were statistically tested with the Kapplan-Meier analysis with 
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a semiparametric log-rank test (Walker et al., 2006), and the analysis was performed with 
GraphPad Prism 4 software. 
 
2.3. ROS staining of fly brains 
 
For ROS staining of adult fly brains, 2,7-dichloroflourescein diacetate (DCFH-DA) 
(Molecular Probes) was used. A 1mM DCFH-DA stock solution was prepared in 
dimethylsulfoxide (DMSO). Brains were dissected in 1xPBS/0.1% Tween 20 and incubated 
with DCFH-DA (50 μM final concentration in 1xPBS) for 40 min at room temperature. After 
two washes with 1xPBS, brains were mounted in antifading solution (Dako) and analyzed in a 
fluorescence microscope (Leica). 
 
2.4. Measurement of lipid hydroperoxides (LPO) 
 
Quantification of lipid peroxidation was carried out by reaction of thiobarbituric acid with 
the malondialdehyde (MDA) product of oxidized fatty acid breakage (Buege and Aust, 1978). 
100 flies (approx. 100 mg) per genotype were homogenized in 0.6 ml of 50 mM sodium 
phosphate buffer, pH 6.0, 10% trichloroacetic acid (TCA) and centrifuged at a speed of 10.000 
rpm for 10 min. The supernatant was divided in two aliquots, 300 μl of supernatant were mixed 
to 100 μl of 0.1 M EDTA and 600 μl of 1% thiobarbituric acid in 0.05 M NaOH, and then 
incubated at 100ºC 15 min. The second aliquot (300 μl) was mixed to 0.7 ml of H2O and 
incubated in the same conditions as described above. This sample was used as an internal 
absorbance control to avoid artifacts in LPO measurement as a consequence of the different eye 
color of y, w control flies and DJ-1βA286  mutants. After cooling on ice and centrifugation at 
10.000 rpm for 1 min to eliminate precipitates, malondialdehyde was measured by the 
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absorbance at 535 nm. The molar absorptivity of MDA (1.56 ×10
5
 M
-1
 cm
-1
) was used to 
express lipid peroxidation levels as pmoles of MDA per mg of flies. 
 
2.5. Catalase activity 
 
Catalase activity was measured by using a protocol adapted from Jakubowski et al. (2000). 
Fifty flies per genotype were homogenized in 200 μl of 50 mM phosphate buffer, pH 7.0, and a 
mix of protease inhibitors (200 μM phenylmethylsulfonyl fluoride (PMSF), 20 μM TPcK, 200 
μM pepstatin A) and assayed by adding 0.1-1 μL of sample to 50 mM phosphate buffer, pH 7.0, 
and 80 mM H2O2. Absorbance decrease was measured at 240 nm and calculations were 
performed using an extinction coefficient of 0.043 mM
-1
cm
-1
ml
-1
. Catalase activity is expressed 
as μmol of H2O2/min/mg of protein. 
 
3. Results and Discussion 
 
3.1. Effects of antiparkinsonian drugs on lifespan of DJ-1βA286 mutant flies 
 
DJ-1βA286 mutant flies are viable, fertile, and display age-dependent motor deficits and a 
significantly shorter lifespan than wild-type flies, but no DA neurodegeneration (Lavara-
Culebras and Paricio, 2007). To determine whether those phenotypes are due to defects in 
dopamine neurotransmission or DA neuron malfunction, as suggested in mice models (Chen et 
al., 2005; Goldberg et al., 2005), several antiparkinsonian drugs used to mitigate the effects of 
DA neuron loss in PD patients were tested for their ability to modify the reduced lifespan 
phenotype of DJ-1βA286 mutants (Fig. 1A). The drugs used in this study were: 3,4-dihydroxy-L-
phenylalanine (L-DOPA), and the dopamine agonists 2,3,4,5-tetrahydro-7,8-dihydroxy-1-
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phenyl-1H-3-benzazepine (SK&F 38393) and pergolide. L-DOPA, a synthetic precursor of 
dopamine biosynthesis (Radad et al., 2005), is the most effective pharmacological symptomatic 
treatment of PD. It has been shown that PD patients have a reduced life expectancy, and that 
treatment with L-DOPA can suppress, but not restore, that reduction in some cases (Lang and 
Lozano, 1998; Dauer and Przedborski, 2003). On the other hand, both dopamine agonists 
activate dopamine receptors: SK&F 38393 is the prototypical D1 receptor agonist (Pendleton et 
al., 1978), and pergolide acts preferentially on the D2 receptor family (Standaert and Young, 
1996). Some of these drugs were shown to improve motor impairments of PD transgenic models 
in Drosophila and mice (Pendleton et al., 2002; Wakamatsu et al., 2007), and to alleviate a 
motility phenotype and DA neurodegeneration in a Drosophila model of hereditary spastic 
paraplegia (Lee et al., 2008). Moreover, pergolide was reported to protect SH-SY5Y 
neuroblastoma cells from H2O2-induced death (Uberti et al., 2003).  
To test whether L-DOPA could rescue the lifespan phenotype of DJ-1βA286 mutants, newly-
eclosed flies were cultured on medium supplemented with 1mM L-DOPA plus ascorbic acid (or 
vitamin C, a water-soluble antioxidant) to avoid oxidation of the drug, or only ascorbic acid as 
control. Due to the genetic background of the DJ-1βA286 mutants, control experiments were 
performed with y, w mutant flies (see Materials and methods). Analyses of treated and untreated 
flies of both genotypes were carried out in parallel to avoid natural fluctuations in lifespan that 
occurs in D. melanogaster in successive generations (Izmaylov and Obukhova, 1999). The same 
experiments were performed in standard food in order to test whether ascorbic acid could have 
an effect by itself on flies’ lifespan. Indeed, previous studies showed that 20 mM ascorbic acid 
supplementation extended the average lifespan of control rosy
+5
 (ry
+5
) flies, although it caused 
early mortality in at a 100 mM concentration (Bahadorani et al., 2008): However, it had not 
significant effect on the short lifespan of SOD1-deficient flies (Bahadorani et al., 2008) and was 
shown to increase the toxicity of paraquat in flies at 0.43 mM (Bonilla et al., 2006). Our results 
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show that median and maximum lifespan values of either control or DJ-1βA286 mutant flies were 
significantly extended after ascorbic acid supplementation (Fig. 1B, p<0.0001). In y, w control 
flies,  1.42 mM (0.25 mg/ml) vitamin C increased median and maximum lifespan values by 
17.5% and 5.1%, respectively. Similar results were obtained for DJ-1β mutants, whose median 
and maximum lifespan values were increased by 19.4% and 8.4%, respectively. However, our 
results show that L-DOPA had no significant effect on longevity of DJ-1βA286 mutants or y, w 
control flies, which present similar survival curves either treated or untreated with the drug (Fig. 
2). One possible explanation could be the existence of a synergistic effect of ascorbic acid and 
L-DOPA on flies’ lifespan. To test this possibility, we have carried out lifespan analyses of DJ-
1βA286 mutants and y, w control flies on medium supplemented with L-DOPA but using 1 mM 
butylated hydroxytoluene (BHT) as alternative antioxidant additive. Preliminary results indicate 
that there are no significant differences in survival curves of flies cultured on medium 
containing BHT or BHT plus L-DOPA (data not shown), thus confirming our previous results. 
Next, we analyzed the effect of SK&F 38393 on lifespan of DJ-1βA286 mutants and wild-
type flies using the same experimental procedure. As for L-DOPA administration, SK&F 38393 
containing medium was supplemented with ascorbic acid (see Materials and methods). We 
found that 1mM SK&F 38393 did not significantly modify lifespan in DJ-1βA286 mutant flies 
(Fig. 3). However, SK&F 38393 supplementation had a weak but significant effect on wild-type 
flies (p<0.0005), increasing their median and maximum lifespan values by 6.3% and 5.2%, 
respectively. It was previously reported that 1 mM SK&F 38393 had no effect on the climbing 
response of wild-type Canton S flies but almost completely reversed the deteriorating motor 
activity in α-synuclein transgenic flies (Pendleton et al., 2002). However, those climbing assays 
were performed after 13 days of treatment with the drug, while we first detect an effect on 
control flies’ lifespan after more than 30 days of treatment in our experiments. Then, it is likely 
that SK&F 38393 supplementation could also have an effect on the motor activity of wild-type 
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flies. Consistent with this, other studies performed in mice showed that SK&F 38393 caused a 
dose-dependent increase in locomotor activity of wild-type animals (Gomeza et al., 1999).  
Finally, when assaying the effect of the dopamine agonist pergolide on the lifespan of DJ-
1βA286 mutants and wild-type flies we found that, in contrast to previous analyses carried out in a 
transgenic model of PD in Drosophila (Pendleton et al., 2002), the drug was toxic at a 1mM 
concentration for both genotypes causing a high mortality (Supplementary Figure 1). To 
determine whether this toxicity was dose-dependent we repeated the lifespan analyses using 0.5 
and 0.25 mM pergolide and found that the drug was still affecting viability in adult flies, thus 
preventing further analyses in our PD Drosophila model. Taken together, our results indicate 
that the reduced lifespan phenotype exhibited by the DJ-1βA286 mutants is not due to defects in 
DA physiology as previously suggested (Lavara-Culebras and Paricio, 2007), since the drugs 
used were not able to suppress that phenotype. 
 
3.2. Effects of antioxidant compounds on lifespan of DJ-1βA286 mutant flies 
 
It has been shown that the DJ-1 protein is involved in oxidative stress response (van der 
Brug et al., 2008; Zhong and Xu, 2008; Blackington et al., 2009). According to this, DJ-1βA286 
mutants exhibited high sensitivity to oxidative stress induced by the herbicide paraquat (Lavara-
Culebras and Paricio, 2007). We then explored the putative involvement of oxidative damage in 
DJ-1β-inactivation-dependent lifespan reduction by treating DJ-1βA286 mutants with compounds 
that exhibit antioxidant activity, including melatonin (N-acetyl-5-methoxytryptamine) and α-
tocopherol. As shown above, ascorbic acid (or vitamin C) was able to significantly increase 
lifespan values in DJ-1βA286 mutants and control flies (see Fig. 1B). Melatonin is a hormone that 
can exert several functions and seems to act as antioxidant and free radical scavenger, 
promoting the response against oxidative injuries (Karasek, 2004; Anisimov et al., 2006), and α-
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tocopherol is a vitamin E isoform that is the most powerful naturally occurring antioxidant 
known to date (Ricciarelli et al., 2001; Tucker and Townsend, 2005). 
First, we analyzed the effect of melatonin treatment on the lifespan of DJ-1βA286 mutants and 
y, w control flies. Our results show that 1mM melatonin significantly increased median lifespan 
values by 7.5% in control flies and by 19.4% in DJ-1β mutants, although maximum lifespan 
values were practically unaffected in both genotypes (Fig. 4). Despite this, we found that 
lifespan curves of untreated and treated flies are significantly different for both genotypes 
(p<0.0001). According to these results, it was reported that chronic treatments with melatonin 
were able to increase lifespan values in effects after in wild-type flies (Oregon R), and also 
survival of flies exposed to paraquat (Izmaylov and Obukhova, 1999; Bonilla et al., 2002, 
2006). Furthermore, melatonin was also shown to rescue locomotor deficits and DA 
neurodegeneration in a Drosophila model of sporadic PD (Coulom and Birman, 2004). 
We next examined the effects of α-tocopherol on the short lifespan phenotype associated to 
DJ-1β loss of function. We found that this phenotype was significantly suppressed by chronic 
treatment of adult flies with 1mM α-tocopherol on (p<0.0001), as evidenced by a 11.1% and 
10.3% increase in median and maximum lifespan values, respectively. However, α-tocopherol 
supplementation did not modify lifespan values in control animals (Figure 5A). Our results are 
consistent with previous studies that showed that α-tocopherol supplementation only extended 
lifespan or suppressed phenotypes either associated to oxidative stress conditions or to 
genetically compromised backgrounds, but had no visible effects on lifespan under normal 
laboratory conditions (Nakashima et al., 2004; Wang et al., 2006; Dias-Santagata et al., 2007; 
Bahadorani et al., 2008). Indeed, it was proposed that wild-type flies retain very little vitamin E 
from the medium, probably due to their low biological needs for this antioxidant (Draper et al., 
2000). However, flies with defective oxidative stress response could retain vitamin E more 
efficiently than wild-type flies (Zou et al., 2007; Bahadorani et al., 2008). Then, α-tocopherol 
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supplementation would strength antioxidant defenses against oxidative injuries, and would 
extend lifespan in such flies. The results obtained in the present study with DJ-1βA286 mutant 
flies, which are highly sensitive to oxidative stress (Lavara-Culebras and Paricio, 2007), would 
confirm this hypothesis. 
Finally, we tested whether there was a sex-dependent effect of antioxidant compounds on 
DJ-1βA286 mutants’ lifespan, since previous reports showed that females have a better response 
to antioxidant treatments than males (Magwere et al., 2006). Confirming those observations, we 
found that although both sexes show a similar increase in their maximum lifespan values after 
α-tocopherol supplementation (13.3% in females and 10.3% in males, Figure 5B), DJ-1βA286 
females exhibit a higher increase of the median lifespan value than males (26.7% and 11.1%, 
respectively). Similar results are obtained after melatonin treatment of DJ-1βA286 mutant flies 
(data not shown). The sex-dependent effects of antioxidant drugs on lifespan may be explained 
by differences in feeding habits, in metabolic rates or in physiological differences in the 
response to oxidative injuries between males and females, as previously suggested (Magwere et 
al., 2006).  
Taken together, our data show that all antioxidant compounds tested were able to 
significantly increase lifespan values in DJ-1βA286 mutants, suggesting that this phenotype is 
very likely caused by deficiencies in the oxidative stress response. 
 
3.3. Quantification of oxidative stress levels in DJ-1βA286 mutant flies 
 
To further confirm that oxidative stress plays a causative role in the lifespan phenotype of 
DJ-1βA286 mutant flies, we decided to measure several physiological markers of oxidative stress 
in such flies. We first used 2,7-dichloroflourescein diacetate (DCFH-DA) staining, which is an 
indicator of hydroxyl-free radical levels, to analyze ROS levels in DJ-1βA286 mutants’ brains. 
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Our results indicate that brains of 1-2-day old DJ-1βA286 flies show an increased DCFH-DA 
staining when compared to brains of age-matched control flies (Fig. 6A-B), thus suggesting that 
loss of DJ-1β function leads to an elevation of ROS levels. Similar results were obtained when 
analyzing fly brains after DJ-1α-inactivation in DA neurons via RNAi (Yang et al., 2006a). As 
indicated in the Introduction, DJ-1α is the second Drosophila DJ-1 ortholog. To further 
investigate whether DJ-1β is involved in cellular response to endogenous oxidative stress, we 
also examined DJ-1βA286 mutant flies for the extent of oxidative damage by determining lipid 
peroxidation (LPO) levels and catalase enzymatic activity. As shown in Fig. 6B the total amount 
of malondialdehyde (MDA), one of the end stage products of lipid peroxidation, in DJ-1βA286 
mutants was significantly higher than in y,w control flies (p<0.05) even in 1-2-day old flies. 
Besides, catalase activity was also significantly increased in these mutants compared to age-
matched control flies (Fig. 6C, p<0.001). The increase of these two markers of oxidative stress 
was also observed in flies subjected to hyperoxia treatment as an oxidative stressor (Gruenewald 
et al., 2009). Taken together, these results support the crucial role of oxidative stress in the 
lifespan phenotype of DJ-1βA286 mutant flies. It has been proposed that the human DJ-1 protein 
may contribute to ROS removal both as a free radical scavenger and a 
transcriptional/translational regulator promoting the expression of genes involved in oxidative 
stress defense (van der Brug et al., 2008; Zhong and Xu, 2008; Blackington et al., 2009). Our 
results indicate that similar functions could be proposed for the Drosophila DJ-1β protein, since 
defects in the oxidative tress response are evident in DJ-1βA286 mutant flies. 
 
3.4. Conclusions 
 
In summary, our results strongly suggest that the reduced lifespan phenotype exhibited by DJ-
1βA286 mutant flies is, at least in part, due to defects in the oxidative stress response, and not in 
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DA physiology as proposed in DJ-1 mice models. Indeed, we show that high levels of oxidative 
stress are detected in DJ-1βA286 mutant flies by using different methods. Confirming this, we 
find that long term dietary supplementation with antioxidants is effective in significantly 
increasing lifespan values of DJ-1βA286 mutants. Similar doses of these drugs have been shown 
to suppress phenotypes associated to oxidative damage in other fly models of human diseases 
(i.e. Wang et al., 2006; Dias-Santagata et al., 2007). Our results also indicate that these 
compounds are not sufficient to completely restore lifespan values observed in control flies. 
This may suggest that DJ-1β loss-of-function does not just limit lifespan through oxidative 
damage, but possibly through introduction of other pathologies that may also be life limiting. 
We also find that, while vitamin C and melatonin (both water-soluble antioxidants) are able to 
extend lifespan in both DJ-1β mutants and wild-type flies, the beneficial effects of α-tocopherol 
(lipophylic antioxidant) appear to be selective to the DJ-1β mutant flies. One explanation could 
be that these mutants may retain the compound more efficiently than wild-type (y, w) controls, 
as previously suggested for other flies with defective oxidative response (Bahadorani et al., 
2008). Alternatively, this result could suggest that loss of DJ-1β function may cause oxidative 
damage to the membranes. Supporting this hypothesis we find a high MDA content in DJ-1β 
mutant flies, which is an indicator of high levels of lipid peroxidation and of free radical 
damage to cell membranes. 
Similar beneficial effects of antioxidant compounds on several mutant backgrounds and 
Drosophila models of human diseases have been reported. Indeed, α-tocopherol 
supplementation has been shown to suppress several phenotypes found in Drosophila models of 
neurodegenerative diseases like taupathies (Dias-Santagata et al., 2007), PD (Wang et al., 2006), 
or pantothenate-kinase-associated neurodegeneration (PKAN, Yang et al., 2005b), and to extend 
lifespan of flies with deficiencies in oxidative stress response (Bahadorani et al., 2008), 
although it could not rescue the lethal phenotype of a Drosophila model of Huntington’s disease 
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(Bahadorani and Hilliker, 2008). Moreover, vitamin E was also effective in suppressing 
phenotypes found in mouse models of human tauopathy (Nakashima et al., 2004) or Down 
syndrome (Lockrow et al., 2009), counterparting the increased oxidative stress observed in 
those models. Regarding this, vitamin E has proved efficacious in reducing markers of oxidative 
stress (Pratico et al., 1998; Hong et al., 2004), restoring endogenous antioxidant enzyme 
functions to normal levels in the mouse model of Down syndrome (Lockrow et al., 2009) and in 
rodent models of oxidative stress (Zaidi and Banu, 2004). Although these effects can be 
achieved through its antioxidant function, the non-antioxidant properties of α-tocopherol in 
modulating gene expression may also play a role (Ricciarelli et al., 2001; 2007; Tucker and 
Townsend, 2005). Then, it can be proposed that α-tocopherol could suppress the lifespan 
phenotype of DJ-1βA286 mutant flies based on its antioxidant function, eliminating ROS and then 
preventing DJ-1β oxidation, but also affecting either some signaling pathways that regulate DJ-
1β oxidation or genes important to fly survival whose expression may be compromised by lack 
of DJ-1β function.  
Our present study further shows that the lifespan phenotype of DJ-1βA286 mutant flies is 
amenable to pharmacological intervention since manipulation of antioxidant defence 
mechanisms with several compounds can modify such phenotype. Interestingly, a recent study 
has shown that treatments with minocycline and celestrol, two drugs with antioxidant and anti-
inflammatory activities, are able to attenuate DA neuron loss and reduction of brain dopamine 
levels as well as locomotor defects associated to DJ-1α-inactivation via RNAi in flies (Faust et 
al., 2009). Treatments with both drugs partially suppress those phenotypes and have no 
significant effect on DA neuron number, dopamine levels or climbing activity in control flies. 
Since DJ-1α is the second ortholog of the human DJ-1 gene in Drosophila, these findings 
emphasize the role of oxidative stress in DJ-1 pathogenesis and support the use of this organism 
as a model to elucidate the molecular mechanisms underlying PD. Thus, Drosophila DJ-1 
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mutants could serve as a good model for pharmacological rescue studies of PD, enabling 
efficient screening of compounds able to suppress PD-like phenotypes. This could lead to the 
identification of novel factors involved in DJ-1-related PD pathogenesis and compounds to 
prevent oxidative stress occurring during PD in humans. 
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Figure legends 
 
Figure 1. Survival curves of y, w control flies and DJ-1βA286 mutants either untreated and after 
chronic treatment with vitamin C. (A) Comparison of survival curves of y, w control flies
 
(black 
squares) and DJ-1A286 mutants cultured in standard fly food. DJ-1A286 mutant flies have a 
significantly shorter lifespan than y, w control flies as determined by using Kaplan-Meier log-
rank statistical test (p<0.0001). (B) Survival curves of y, w control flies and DJ-1βA286 mutants 
after chronic treatment with 0.25 mg/ml (~ 1.42 mM) vitamin C. Flies of both genotypes treated 
with ascorbic acid (open triangles) show significant increase of their lifespan values. The 
median and maximum lifespan values are as follows: y, w untreated 40 and 67.5 days; y, w 
treated with ascorbic acid 47 and 71 days; DJ-1βA286 untreated 36 and 53.5 days; DJ-1βA286 
treated 43 and 58 days. The significance of the difference between survival curves of treated and 
untreated flies was analyzed using the Kaplan-Meier log-rank statistical test (p<0.0001 in both 
cases). 
 
Figure 2. Survival curves of y, w control flies and DJ-1βA286 mutants after chronic treatment 
with 1mM L-DOPA. The median and maximum lifespan values are as follows: y, w untreated or 
treated with L-DOPA 43 and 71 days; DJ-1βA286 untreated 45 and 58 days; DJ-1βA286 treated 47 
and 59 days. For both genotypes, there are not significant differences between untreated (black 
squares) and L-DOPA treated flies (open triangles) as determined by using the Kaplan-Meier 
log-rank statistical test. 
 
Figure 3. Survival curves of y, w control flies and DJ-1βA286 mutants after chronic treatment 
with 1mM SK&F 38393. The median and maximum lifespan values are as follows: y, w 
untreated 47 and 67.5 days; y, w treated with SK&F 38393 50 and 71 days; DJ-1βA286 untreated 
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36 and 53.5 days; DJ-1βA286 treated 38 and 55.5 days. Treated y, w control flies (open triangles) 
show a mild but significant increase of their lifespan values when compared to untreated y, w 
flies (black squares) as determined by using Kaplan-Meier log-rank statistical test (p<0.0005). 
In contrast, SK&F 38393 treated and untreated DJ-1βA286mutants do not show significant 
differences.  
 
Figure 4. Survival curves of y, w control flies and DJ-1βA286 mutants after chronic treatment 
with 1mM melatonin. The median and maximum lifespan values are as follows: y, w untreated 
40 and 62.5 days; y, w treated with melatonin 43 and 64 days; DJ-1βA286 untreated 36 and 57 
days; DJ-1βA286 treated 43 and 55.5 days. Melatonin treatment results in a mild but statistically 
significant increase of their lifespan values (especially of median lifespan) in both genotypes. 
The significance of the difference between survival curves of treated and untreated flies was 
analyzed using the Kaplan-Meier log-rank statistical test (p<0.0001 for both genotypes). 
 
Figure 5. Survival curves of y, w control flies and DJ-1βA286 mutants after chronic treatment 
with 1mM α-tocopherol. (A) Comparison of survival curves of control and DJ-1βA286 flies after 
chronic treatment with 1mM α-tocopherol. The median and maximum lifespan values are as 
follows: y, w untreated 40 and 68.5 days; y, w treated with α-tocopherol 40 and 61,5 days; DJ-
1βA286 untreated 36 and 48.5 days; DJ-1βA286 treated 40 and 53,5 days. α-tocopherol 
supplementation results in a significant increase of DJ-1βA286 mutants lifespan values as 
determined by using Kaplan-Meier log-rank statistical test (p<0.0001). In contrast, y, w flies do 
not show significant changes in their lifespan values. (B) Survival curves of male and female 
DJ-1βA286 mutant flies after chronic treatment with 1mM α-tocopherol. The median and 
maximum lifespan values are as follows: DJ-1βA286 males untreated 36 and 48.5 days; DJ-1βA286 
males treated 40 and 53.4 days; DJ-1βA286 females untreated 30 and 44 days; DJ-1βA286 females 
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treated 38 and 50 days. In both sexes, α-tocopherol supplementation significantly extends 
lifespan as determined by using Kaplan-Meier log-rank statistical test (p<0.0001 in both cases). 
However, females show higher increase of the lifespan values than males. 
 
Figure 6. Oxidative stress markers in y, w control flies and DJ-1βA286 mutants. (A-B) DCFH-
DA staining of whole-mount adult brains from 1-2-day-old y, w and DJ-1βA286 flies. Weak 
signals in A represent a combination of weak ROS staining and autofluorescence of adult fly 
brains. Note that loss of DJ-1β function leads to an elevation of ROS levels (compare A with 
B). (C) Increase in lipid peroxidation (LPO) product malondialdehyde (MDA) in 1-2-day old 
DJ-1βA286 mutants compared to age-matched y, w control flies (p<0.05). (D) Catalase (CAT) 
enzymatic activity is also increased in 1-2-day old DJ-1βA286 mutants compared to age-matched 
y, w control flies (p<0.001). In C and D data are expressed as mean and standard deviation of 
replicate determinations for 4 and 3 samples, respectively.  
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Abstract 
 
Mutations in the DJ-1 gene cause autosomal recessive, early-onset Parkinsonism. The DJ-1 
protein exerts a protective role against oxidative stress damage, working as a cellular oxidative 
stress sensor, and it seems to regulate gene expression at different levels. In Drosophila, two 
DJ-1 orthologs have been identified: DJ-1α and DJ-1β. Several studies have shown that loss of 
DJ-1β function causes Parkinson’s disease (PD)-like phenotypes in flies such as age-dependent 
locomotor defects, reduced lifespan, and enhanced sensitivity to toxins that induce oxidative 
stress, like the herbicide paraquat. However, no dopaminergic neurodegeneration is observed. 
These results suggested that both locomotor and lifespan phenotypes could be either related to 
defects in oxidative stress response, or in dopaminergic physiology as proposed in mice models. 
In this study, we have employed pharmacological approaches to modify the lifespan phenotype 
of DJ-1β mutant flies. We have assessed the effects of chronic treatments with antiparkinsonian 
drugs as well as with antioxidant compounds on such phenotype finding that only antioxidants 
show statistically significant beneficial effects on DJ-1β mutants’ lifespan. These results 
strongly suggest that oxidative stress plays a causal role in the lifespan phenotype of DJ-1β 
mutants. Consistent with this, we find that loss of DJ-1β function results in cellular 
accumulation of reactive oxygen species (ROS) in adult brains, elevated levels of lipid 
peroxidation and an increased catalase enzymatic activity, thus indicating the existence of high 
oxidative stress levels in DJ-1β mutants and confirming the essential function of the DJ-1β 
protein in protecting the organism against oxidative insults. Our study further shows that the 
lifespan phenotype of DJ-1β mutant flies is amenable to pharmacological intervention , and 
validates Drosophila as a valuable model for testing and identifying new drugs with therapeutic 
potential for PD. 
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1. Introduction 
 
Parkinson’s disease (PD) is the second most common neurodegenerative disorder. Although 
most PD cases are sporadic, several genes are associated with familial disease providing 
important insights into PD pathogenesis (Schultz, 2008). One of them is PARK7 whose 
mutations cause autosomal recessive, early-onset Parkinsonism (Bonifati et al., 2003). PARK7 
(or DJ-1) encodes DJ-1, a small protein that was originally identified as an oncogenic factor 
(Nagakubo et al., 1997). However, studies in cell culture and animal models have demonstrated 
that the DJ-1 protein exerts a protective role against oxidative stress damage, being modified in 
several cysteine residues under these conditions (Canet-Aviles et al., 2004; Betarbet et al., 2006; 
Choi et al., 2006; Meulener et al., 2006). This modification increases with age and exposure to 
oxidative toxins, probably leading to DJ-1 inactivation and eventually predisposing 
dopaminergic (DA) neurons to stress-induced degeneration. Although the molecular function of 
DJ-1 is unclear, it seems that it can regulate gene expression either at the transcriptional or 
translational level and, interestingly, both functions are impaired by oxidation (van der Brug et 
al., 2008; Zhong and Xu, 2008; Blackington et al. 2009). It has been proposed a model whereby 
DJ-1 interacts with mRNAs and dissociates under conditions of oxidative stress, thus the 
apparent pleiotropic effects of DJ-1 may be related to the single function of binding to multiple 
transcripts (van der Brug et al., 2008). 
In Drosophila, two DJ-1 orthologs have been identified, DJ-1α and DJ-1β. Loss of function 
of these genes cause defects in oxidative stress response and locomotion as well as shortened 
lifespan, but only inactivation of DJ-1α expression via RNAi results in DA neurodegeneration 
(Meulener et al., 2005; Menzies et al., 2005; Park et al., 2005; Yang et al., 2005a; Lavara-
Culebras and Paricio, 2007). DJ-1βA286 mutant flies were characterized in our laboratory and 
contain a transposable element insertion in the DJ-1β gene, thus encoding a truncated and 
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probably inactive DJ-1β protein. Despite this, they are viable and fertile but show motor 
impairments and a significantly shorter lifespan than wild-type flies. Moreover, they are highly 
sensitive to paraquat exposure (Lavara-Culebras and Paricio, 2007). Since loss of DJ-1β 
function does not affect DA neuron survival (Menzies et al., 2005; Meulener et al., 2005; Park 
et al., 2005; Lavara-Culebras and Paricio, 2007), one possibility is that the observed motor and 
lifespan phenotypes are due to defects in dopamine neurotransmission or DA neuron 
malfunction, as suggested in mice models (Chen et al., 2005; Goldberg et al., 2005). 
Alternatively, they could be caused by oxidative damage. Supporting this, it was previously 
shown that age-dependent locomotor defects exhibited by DJ-1β mutants carrying a different 
allele were substantially enhanced by paraquat treatment (Park et al., 2005). Furthermore, a 
recent study has shown that two compounds with antioxidant and anti-inflammatory properties 
partially suppress DA neuron loss and locomotor dysfunction of DJ-1α RNAi flies (Faust et al., 
2009). In such a scenario, we have investigated the molecular mechanisms involved in the 
lifespan phenotype of DJ-1βA286 mutant flies, by testing the effects on this phenotype of several 
compounds that were added to the flies’ diet. In this study, DJ-1β mutant flies were chronically 
treated with representatives of the major classes of drugs used to mitigate the effects of 
dopaminergic neuron loss in PD patients, like L-DOPA or pergolide, and the experimental 
compound SK&F 38393, as well as with compounds that exhibit antioxidant activity, including 
vitamin C, melatonin or α-tocopherol. We find that lifespan of DJ-1βA286 mutants is 
significantly extended after chronic treatments with antioxidant agents but it is unaffected by 
exposure to antiparkinsonian drugs. Although lifespan values are not restored to wild-type in the 
DJ-1β mutant flies, our results indicate that the lifespan phenotype is mediated, at least in part, 
by oxidative damage and not by defects in DA neuron physiology as previously suggested 
(Lavara-Culebras and Paricio, 2007). Confirming these results, we have observed an increase in 
several markers of oxidative stress in DJ-1βA286 mutants when compared to control flies. 
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2. Materials and methods 
 
2.1. Drosophila stocks and drug feeding 
 
The stocks used in this study (y
1
 w
1118
; PBac{5HPw
+
}DJ-1βA286 and y1, w1118) were obtained 
from the Bloomington Stock Center. Flies were cultured on standard food supplemented with 
antiparkinsonian drugs like L-DOPA, SK&F 38393 and pergolide, or with the antioxidant 
compounds α-tocopherol and melatonin (purchased from Sigma) at a final concentration of 1 
mM, unless otherwise stated. In non-treatment control experiments, flies were fed standard food 
containing the corresponding solvents recommended by the suppliers for each compound. 
Ascorbic acid (0.25 mg/ml) was also added to food containing L-DOPA and SK&F 38393 to 
prevent drug oxidation. In both cases, standard food containing 0.25 mg/ml of ascorbic acid was 
used as non-treatment control. L-DOPA treatment was also performed by using butylated 
hydroxytoluene (BHT) as antioxidant, and standard food containing 1 mM BHT was used as 
non-treatment control in this case. Drug and control feeding trials were carried out at 25ºC from 
day 1-2 after eclosion through adulthood in standard vials containing 1.5 or 2 ml of medium. 
 
2.2 Lifespan assays 
 
Cohorts of 200 1-2-day-old DJ-1βA286 mutants or y, w control flies were collected and tested 
for each drug. Flies were separated by sex and divided in groups of 25 individuals. Those 
groups were put into vials with control or supplemented food. Every second or third day, flies 
were transferred to new vials and the number of dead flies in each vial was scored. This process 
was followed until all flies died, and the percentage of flies alive at each time point was graphed 
(Greene et al., 2003). The results were statistically tested with the Kapplan-Meier analysis with 
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a semiparametric log-rank test (Walker et al., 2006), and the analysis was performed with 
GraphPad Prism 4 software. 
 
2.3. ROS staining of fly brains 
 
For ROS staining of adult fly brains, 2,7-dichloroflourescein diacetate (DCFH-DA) 
(Molecular Probes) was used. A 1mM DCFH-DA stock solution was prepared in 
dimethylsulfoxide (DMSO). Brains were dissected in 1xPBS/0.1% Tween 20 and incubated 
with DCFH-DA (50 μM final concentration in 1xPBS) for 40 min at room temperature. After 
two washes with 1xPBS, brains were mounted in antifading solution (Dako) and analyzed in a 
fluorescence microscope (Leica). 
 
2.4. Measurement of lipid hydroperoxides (LPO) 
 
Quantification of lipid peroxidation was carried out by reaction of thiobarbituric acid with 
the malondialdehyde (MDA) product of oxidized fatty acid breakage (Buege and Aust, 1978). 
100 flies (approx. 100 mg) per genotype were homogenized in 0.6 ml of 50 mM sodium 
phosphate buffer, pH 6.0, 10% trichloroacetic acid (TCA) and centrifuged at a speed of 10.000 
rpm for 10 min. The supernatant was divided in two aliquots, 300 μl of supernatant were mixed 
to 100 μl of 0.1 M EDTA and 600 μl of 1% thiobarbituric acid in 0.05 M NaOH, and then 
incubated at 100ºC 15 min. The second aliquot (300 μl) was mixed to 0.7 ml of H2O and 
incubated in the same conditions as described above. This sample was used as an internal 
absorbance control to avoid artifacts in LPO measurement as a consequence of the different eye 
color of y, w control flies and DJ-1βA286  mutants. After cooling on ice and centrifugation at 
10.000 rpm for 1 min to eliminate precipitates, malondialdehyde was measured by the 
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absorbance at 535 nm. The molar absorptivity of MDA (1.56 ×10
5
 M
-1
 cm
-1
) was used to 
express lipid peroxidation levels as pmoles of MDA per mg of flies. 
 
2.5. Catalase activity 
 
Catalase activity was measured by using a protocol adapted from Jakubowski et al. (2000). 
Fifty flies per genotype were homogenized in 200 μl of 50 mM phosphate buffer, pH 7.0, and a 
mix of protease inhibitors (200 μM phenylmethylsulfonyl fluoride (PMSF), 20 μM TPcK, 200 
μM pepstatin A) and assayed by adding 0.1-1 μL of sample to 50 mM phosphate buffer, pH 7.0, 
and 80 mM H2O2. Absorbance decrease was measured at 240 nm and calculations were 
performed using an extinction coefficient of 0.043 mM
-1
cm
-1
ml
-1
. Catalase activity is expressed 
as μmol of H2O2/min/mg of protein. 
 
3. Results and Discussion 
 
3.1. Effects of antiparkinsonian drugs on lifespan of DJ-1βA286 mutant flies 
 
DJ-1βA286 mutant flies are viable, fertile, and display age-dependent motor deficits and a 
significantly shorter lifespan than wild-type flies, but no DA neurodegeneration (Lavara-
Culebras and Paricio, 2007). To determine whether those phenotypes are due to defects in 
dopamine neurotransmission or DA neuron malfunction, as suggested in mice models (Chen et 
al., 2005; Goldberg et al., 2005), several antiparkinsonian drugs used to mitigate the effects of 
DA neuron loss in PD patients were tested for their ability to modify the reduced lifespan 
phenotype of DJ-1βA286 mutants (Fig. 1A). The drugs used in this study were: 3,4-dihydroxy-L-
phenylalanine (L-DOPA), and the dopamine agonists 2,3,4,5-tetrahydro-7,8-dihydroxy-1-
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phenyl-1H-3-benzazepine (SK&F 38393) and pergolide. L-DOPA, a synthetic precursor of 
dopamine biosynthesis (Radad et al., 2005), is the most effective pharmacological symptomatic 
treatment of PD. It has been shown that PD patients have a reduced life expectancy, and that 
treatment with L-DOPA can suppress, but not restore, that reduction in some cases (Lang and 
Lozano, 1998; Dauer and Przedborski, 2003). On the other hand, both dopamine agonists 
activate dopamine receptors: SK&F 38393 is the prototypical D1 receptor agonist (Pendleton et 
al., 1978), and pergolide acts preferentially on the D2 receptor family (Standaert and Young, 
1996). Some of these drugs were shown to improve motor impairments of PD transgenic models 
in Drosophila and mice (Pendleton et al., 2002; Wakamatsu et al., 2007), and to alleviate a 
motility phenotype and DA neurodegeneration in a Drosophila model of hereditary spastic 
paraplegia (Lee et al., 2008). Moreover, pergolide was reported to protect SH-SY5Y 
neuroblastoma cells from H2O2-induced death (Uberti et al., 2003).  
To test whether L-DOPA could rescue the lifespan phenotype of DJ-1βA286 mutants, newly-
eclosed flies were cultured on medium supplemented with 1mM L-DOPA plus ascorbic acid (or 
vitamin C, a water-soluble antioxidant) to avoid oxidation of the drug, or only ascorbic acid as 
control. Due to the genetic background of the DJ-1βA286 mutants, control experiments were 
performed with y, w mutant flies (see Materials and methods). Analyses of treated and untreated 
flies of both genotypes were carried out in parallel to avoid natural fluctuations in lifespan that 
occurs in D. melanogaster in successive generations (Izmaylov and Obukhova, 1999). The same 
experiments were performed in standard food in order to test whether ascorbic acid could have 
an effect by itself on flies’ lifespan. Indeed, previous studies showed that 20 mM ascorbic acid 
supplementation extended the average lifespan of control rosy
+5
 (ry
+5
) flies, although it caused 
early mortality in at a 100 mM concentration (Bahadorani et al., 2008): However, it had not 
significant effect on the short lifespan of SOD1-deficient flies (Bahadorani et al., 2008) and was 
shown to increase the toxicity of paraquat in flies at 0.43 mM (Bonilla et al., 2006). Our results 
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show that median and maximum lifespan values of either control or DJ-1βA286 mutant flies were 
significantly extended after ascorbic acid supplementation (Fig. 1B, p<0.0001). In y, w control 
flies,  1.42 mM (0.25 mg/ml) vitamin C increased median and maximum lifespan values by 
17.5% and 5.1%, respectively. Similar results were obtained for DJ-1β mutants, whose median 
and maximum lifespan values were increased by 19.4% and 8.4%, respectively. However, our 
results show that L-DOPA had no significant effect on longevity of DJ-1βA286 mutants or y, w 
control flies, which present similar survival curves either treated or untreated with the drug (Fig. 
2). One possible explanation could be the existence of a synergistic effect of ascorbic acid and 
L-DOPA on flies’ lifespan. To test this possibility, we have carried out lifespan analyses of DJ-
1βA286 mutants and y, w control flies on medium supplemented with L-DOPA but using 1 mM 
butylated hydroxytoluene (BHT) as alternative antioxidant additive. Preliminary results indicate 
that there are no significant differences in survival curves of flies cultured on medium 
containing BHT or BHT plus L-DOPA (data not shown), thus confirming our previous results. 
Next, we analyzed the effect of SK&F 38393 on lifespan of DJ-1βA286 mutants and wild-
type flies using the same experimental procedure. As for L-DOPA administration, SK&F 38393 
containing medium was supplemented with ascorbic acid (see Materials and methods). We 
found that 1mM SK&F 38393 did not significantly modify lifespan in DJ-1βA286 mutant flies 
(Fig. 3). However, SK&F 38393 supplementation had a weak but significant effect on wild-type 
flies (p<0.0005), increasing their median and maximum lifespan values by 6.3% and 5.2%, 
respectively. It was previously reported that 1 mM SK&F 38393 had no effect on the climbing 
response of wild-type Canton S flies but almost completely reversed the deteriorating motor 
activity in α-synuclein transgenic flies (Pendleton et al., 2002). However, those climbing assays 
were performed after 13 days of treatment with the drug, while we first detect an effect on 
control flies’ lifespan after more than 30 days of treatment in our experiments. Then, it is likely 
that SK&F 38393 supplementation could also have an effect on the motor activity of wild-type 
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flies. Consistent with this, other studies performed in mice showed that SK&F 38393 caused a 
dose-dependent increase in locomotor activity of wild-type animals (Gomeza et al., 1999).  
Finally, when assaying the effect of the dopamine agonist pergolide on the lifespan of DJ-
1βA286 mutants and wild-type flies we found that, in contrast to previous analyses carried out in a 
transgenic model of PD in Drosophila (Pendleton et al., 2002), the drug was toxic at a 1mM 
concentration for both genotypes causing a high mortality (Supplementary Figure 1). To 
determine whether this toxicity was dose-dependent we repeated the lifespan analyses using 0.5 
and 0.25 mM pergolide and found that the drug was still affecting viability in adult flies, thus 
preventing further analyses in our PD Drosophila model. Taken together, our results indicate 
that the reduced lifespan phenotype exhibited by the DJ-1βA286 mutants is not due to defects in 
DA physiology as previously suggested (Lavara-Culebras and Paricio, 2007), since the drugs 
used were not able to suppress that phenotype. 
 
3.2. Effects of antioxidant compounds on lifespan of DJ-1βA286 mutant flies 
 
It has been shown that the DJ-1 protein is involved in oxidative stress response (van der 
Brug et al., 2008; Zhong and Xu, 2008; Blackington et al., 2009). According to this, DJ-1βA286 
mutants exhibited high sensitivity to oxidative stress induced by the herbicide paraquat (Lavara-
Culebras and Paricio, 2007). We then explored the putative involvement of oxidative damage in 
DJ-1β-inactivation-dependent lifespan reduction by treating DJ-1βA286 mutants with compounds 
that exhibit antioxidant activity, including melatonin (N-acetyl-5-methoxytryptamine) and α-
tocopherol. As shown above, ascorbic acid (or vitamin C) was able to significantly increase 
lifespan values in DJ-1βA286 mutants and control flies (see Fig. 1B). Melatonin is a hormone that 
can exert several functions and seems to act as antioxidant and free radical scavenger, 
promoting the response against oxidative injuries (Karasek, 2004; Anisimov et al., 2006), and α-
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tocopherol is a vitamin E isoform that is the most powerful naturally occurring antioxidant 
known to date (Ricciarelli et al., 2001; Tucker and Townsend, 2005). 
First, we analyzed the effect of melatonin treatment on the lifespan of DJ-1βA286 mutants and 
y, w control flies. Our results show that 1mM melatonin significantly increased median lifespan 
values by 7.5% in control flies and by 19.4% in DJ-1β mutants, although maximum lifespan 
values were practically unaffected in both genotypes (Fig. 4). Despite this, we found that 
lifespan curves of untreated and treated flies are significantly different for both genotypes 
(p<0.0001). According to these results, it was reported that chronic treatments with melatonin 
were able to increase lifespan values in effects after in wild-type flies (Oregon R), and also 
survival of flies exposed to paraquat (Izmaylov and Obukhova, 1999; Bonilla et al., 2002, 
2006). Furthermore, melatonin was also shown to rescue locomotor deficits and DA 
neurodegeneration in a Drosophila model of sporadic PD (Coulom and Birman, 2004). 
We next examined the effects of α-tocopherol on the short lifespan phenotype associated to 
DJ-1β loss of function. We found that this phenotype was significantly suppressed by chronic 
treatment of adult flies with 1mM α-tocopherol on (p<0.0001), as evidenced by a 11.1% and 
10.3% increase in median and maximum lifespan values, respectively. However, α-tocopherol 
supplementation did not modify lifespan values in control animals (Figure 5A). Our results are 
consistent with previous studies that showed that α-tocopherol supplementation only extended 
lifespan or suppressed phenotypes either associated to oxidative stress conditions or to 
genetically compromised backgrounds, but had no visible effects on lifespan under normal 
laboratory conditions (Nakashima et al., 2004; Wang et al., 2006; Dias-Santagata et al., 2007; 
Bahadorani et al., 2008). Indeed, it was proposed that wild-type flies retain very little vitamin E 
from the medium, probably due to their low biological needs for this antioxidant (Draper et al., 
2000). However, flies with defective oxidative stress response could retain vitamin E more 
efficiently than wild-type flies (Zou et al., 2007; Bahadorani et al., 2008). Then, α-tocopherol 
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supplementation would strength antioxidant defenses against oxidative injuries, and would 
extend lifespan in such flies. The results obtained in the present study with DJ-1βA286 mutant 
flies, which are highly sensitive to oxidative stress (Lavara-Culebras and Paricio, 2007), would 
confirm this hypothesis. 
Finally, we tested whether there was a sex-dependent effect of antioxidant compounds on 
DJ-1βA286 mutants’ lifespan, since previous reports showed that females have a better response 
to antioxidant treatments than males (Magwere et al., 2006). Confirming those observations, we 
found that although both sexes show a similar increase in their maximum lifespan values after 
α-tocopherol supplementation (13.3% in females and 10.3% in males, Figure 5B), DJ-1βA286 
females exhibit a higher increase of the median lifespan value than males (26.7% and 11.1%, 
respectively). Similar results are obtained after melatonin treatment of DJ-1βA286 mutant flies 
(data not shown). The sex-dependent effects of antioxidant drugs on lifespan may be explained 
by differences in feeding habits, in metabolic rates or in physiological differences in the 
response to oxidative injuries between males and females, as previously suggested (Magwere et 
al., 2006).  
Taken together, our data show that all antioxidant compounds tested were able to 
significantly increase lifespan values in DJ-1βA286 mutants, suggesting that this phenotype is 
very likely caused by deficiencies in the oxidative stress response. 
 
3.3. Quantification of oxidative stress levels in DJ-1βA286 mutant flies 
 
To further confirm that oxidative stress plays a causative role in the lifespan phenotype of 
DJ-1βA286 mutant flies, we decided to measure several physiological markers of oxidative stress 
in such flies. We first used 2,7-dichloroflourescein diacetate (DCFH-DA) staining, which is an 
indicator of hydroxyl-free radical levels, to analyze ROS levels in DJ-1βA286 mutants’ brains. 
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Our results indicate that brains of 1-2-day old DJ-1βA286 flies show an increased DCFH-DA 
staining when compared to brains of age-matched control flies (Fig. 6A-B), thus suggesting that 
loss of DJ-1β function leads to an elevation of ROS levels. Similar results were obtained when 
analyzing fly brains after DJ-1α-inactivation in DA neurons via RNAi (Yang et al., 2006a). As 
indicated in the Introduction, DJ-1α is the second Drosophila DJ-1 ortholog. To further 
investigate whether DJ-1β is involved in cellular response to endogenous oxidative stress, we 
also examined DJ-1βA286 mutant flies for the extent of oxidative damage by determining lipid 
peroxidation (LPO) levels and catalase enzymatic activity. As shown in Fig. 6B the total amount 
of malondialdehyde (MDA), one of the end stage products of lipid peroxidation, in DJ-1βA286 
mutants was significantly higher than in y,w control flies (p<0.05) even in 1-2-day old flies. 
Besides, catalase activity was also significantly increased in these mutants compared to age-
matched control flies (Fig. 6C, p<0.001). The increase of these two markers of oxidative stress 
was also observed in flies subjected to hyperoxia treatment as an oxidative stressor (Gruenewald 
et al., 2009). Taken together, these results support the crucial role of oxidative stress in the 
lifespan phenotype of DJ-1βA286 mutant flies. It has been proposed that the human DJ-1 protein 
may contribute to ROS removal both as a free radical scavenger and a 
transcriptional/translational regulator promoting the expression of genes involved in oxidative 
stress defense (van der Brug et al., 2008; Zhong and Xu, 2008; Blackington et al., 2009). Our 
results indicate that similar functions could be proposed for the Drosophila DJ-1β protein, since 
defects in the oxidative tress response are evident in DJ-1βA286 mutant flies. 
 
3.4. Conclusions 
 
In summary, our results strongly suggest that the reduced lifespan phenotype exhibited by DJ-
1βA286 mutant flies is, at least in part, due to defects in the oxidative stress response, and not in 
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DA physiology as proposed in DJ-1 mice models. Indeed, we show that high levels of oxidative 
stress are detected in DJ-1βA286 mutant flies by using different methods. Confirming this, we 
find that long term dietary supplementation with antioxidants is effective in significantly 
increasing lifespan values of DJ-1βA286 mutants. Similar doses of these drugs have been shown 
to suppress phenotypes associated to oxidative damage in other fly models of human diseases 
(i.e. Wang et al., 2006; Dias-Santagata et al., 2007). Our results also indicate that these 
compounds are not sufficient to completely restore lifespan values observed in control flies. 
This may suggest that DJ-1β loss-of-function does not just limit lifespan through oxidative 
damage, but possibly through introduction of other pathologies that may also be life limiting. 
We also find that, while vitamin C and melatonin (both water-soluble antioxidants) are able to 
extend lifespan in both DJ-1β mutants and wild-type flies, the beneficial effects of α-tocopherol 
(lipophylic antioxidant) appear to be selective to the DJ-1β mutant flies. One explanation could 
be that these mutants may retain the compound more efficiently than wild-type (y, w) controls, 
as previously suggested for other flies with defective oxidative response (Bahadorani et al., 
2008). Alternatively, this result could suggest that loss of DJ-1β function may cause oxidative 
damage to the membranes. Supporting this hypothesis we find a high MDA content in DJ-1β 
mutant flies, which is an indicator of high levels of lipid peroxidation and of free radical 
damage to cell membranes. 
Similar beneficial effects of antioxidant compounds on several mutant backgrounds and 
Drosophila models of human diseases have been reported. Indeed, α-tocopherol 
supplementation has been shown to suppress several phenotypes found in Drosophila models of 
neurodegenerative diseases like taupathies (Dias-Santagata et al., 2007), PD (Wang et al., 2006), 
or pantothenate-kinase-associated neurodegeneration (PKAN, Yang et al., 2005b), and to extend 
lifespan of flies with deficiencies in oxidative stress response (Bahadorani et al., 2008), 
although it could not rescue the lethal phenotype of a Drosophila model of Huntington’s disease 
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(Bahadorani and Hilliker, 2008). Moreover, vitamin E was also effective in suppressing 
phenotypes found in mouse models of human tauopathy (Nakashima et al., 2004) or Down 
syndrome (Lockrow et al., 2009), counterparting the increased oxidative stress observed in 
those models. Regarding this, vitamin E has proved efficacious in reducing markers of oxidative 
stress (Pratico et al., 1998; Hong et al., 2004), restoring endogenous antioxidant enzyme 
functions to normal levels in the mouse model of Down syndrome (Lockrow et al., 2009) and in 
rodent models of oxidative stress (Zaidi and Banu, 2004). Although these effects can be 
achieved through its antioxidant function, the non-antioxidant properties of α-tocopherol in 
modulating gene expression may also play a role (Ricciarelli et al., 2001; 2007; Tucker and 
Townsend, 2005). Then, it can be proposed that α-tocopherol could suppress the lifespan 
phenotype of DJ-1βA286 mutant flies based on its antioxidant function, eliminating ROS and then 
preventing DJ-1β oxidation, but also affecting either some signaling pathways that regulate DJ-
1β oxidation or genes important to fly survival whose expression may be compromised by lack 
of DJ-1β function.  
Our present study further shows that the lifespan phenotype of DJ-1βA286 mutant flies is 
amenable to pharmacological intervention since manipulation of antioxidant defence 
mechanisms with several compounds can modify such phenotype. Interestingly, a recent study 
has shown that treatments with minocycline and celestrol, two drugs with antioxidant and anti-
inflammatory activities, are able to attenuate DA neuron loss and reduction of brain dopamine 
levels as well as locomotor defects associated to DJ-1α-inactivation via RNAi in flies (Faust et 
al., 2009). Treatments with both drugs partially suppress those phenotypes and have no 
significant effect on DA neuron number, dopamine levels or climbing activity in control flies. 
Since DJ-1α is the second ortholog of the human DJ-1 gene in Drosophila, these findings 
emphasize the role of oxidative stress in DJ-1 pathogenesis and support the use of this organism 
as a model to elucidate the molecular mechanisms underlying PD. Thus, Drosophila DJ-1 
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mutants could serve as a good model for pharmacological rescue studies of PD, enabling 
efficient screening of compounds able to suppress PD-like phenotypes. This could lead to the 
identification of novel factors involved in DJ-1-related PD pathogenesis and compounds to 
prevent oxidative stress occurring during PD in humans. 
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Figure legends 
 
Figure 1. Survival curves of y, w control flies and DJ-1βA286 mutants either untreated and after 
chronic treatment with vitamin C. (A) Comparison of survival curves of y, w control flies
 
(black 
squares) and DJ-1A286 mutants cultured in standard fly food. DJ-1A286 mutant flies have a 
significantly shorter lifespan than y, w control flies as determined by using Kaplan-Meier log-
rank statistical test (p<0.0001). (B) Survival curves of y, w control flies and DJ-1βA286 mutants 
after chronic treatment with 0.25 mg/ml (~ 1.42 mM) vitamin C. Flies of both genotypes treated 
with ascorbic acid (open triangles) show significant increase of their lifespan values. The 
median and maximum lifespan values are as follows: y, w untreated 40 and 67.5 days; y, w 
treated with ascorbic acid 47 and 71 days; DJ-1βA286 untreated 36 and 53.5 days; DJ-1βA286 
treated 43 and 58 days. The significance of the difference between survival curves of treated and 
untreated flies was analyzed using the Kaplan-Meier log-rank statistical test (p<0.0001 in both 
cases). 
 
Figure 2. Survival curves of y, w control flies and DJ-1βA286 mutants after chronic treatment 
with 1mM L-DOPA. The median and maximum lifespan values are as follows: y, w untreated or 
treated with L-DOPA 43 and 71 days; DJ-1βA286 untreated 45 and 58 days; DJ-1βA286 treated 47 
and 59 days. For both genotypes, there are not significant differences between untreated (black 
squares) and L-DOPA treated flies (open triangles) as determined by using the Kaplan-Meier 
log-rank statistical test. 
 
Figure 3. Survival curves of y, w control flies and DJ-1βA286 mutants after chronic treatment 
with 1mM SK&F 38393. The median and maximum lifespan values are as follows: y, w 
untreated 47 and 67.5 days; y, w treated with SK&F 38393 50 and 71 days; DJ-1βA286 untreated 
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36 and 53.5 days; DJ-1βA286 treated 38 and 55.5 days. Treated y, w control flies (open triangles) 
show a mild but significant increase of their lifespan values when compared to untreated y, w 
flies (black squares) as determined by using Kaplan-Meier log-rank statistical test (p<0.0005). 
In contrast, SK&F 38393 treated and untreated DJ-1βA286mutants do not show significant 
differences.  
 
Figure 4. Survival curves of y, w control flies and DJ-1βA286 mutants after chronic treatment 
with 1mM melatonin. The median and maximum lifespan values are as follows: y, w untreated 
40 and 62.5 days; y, w treated with melatonin 43 and 64 days; DJ-1βA286 untreated 36 and 57 
days; DJ-1βA286 treated 43 and 55.5 days. Melatonin treatment results in a mild but statistically 
significant increase of their lifespan values (especially of median lifespan) in both genotypes. 
The significance of the difference between survival curves of treated and untreated flies was 
analyzed using the Kaplan-Meier log-rank statistical test (p<0.0001 for both genotypes). 
 
Figure 5. Survival curves of y, w control flies and DJ-1βA286 mutants after chronic treatment 
with 1mM α-tocopherol. (A) Comparison of survival curves of control and DJ-1βA286 flies after 
chronic treatment with 1mM α-tocopherol. The median and maximum lifespan values are as 
follows: y, w untreated 40 and 68.5 days; y, w treated with α-tocopherol 40 and 61,5 days; DJ-
1βA286 untreated 36 and 48.5 days; DJ-1βA286 treated 40 and 53,5 days. α-tocopherol 
supplementation results in a significant increase of DJ-1βA286 mutants lifespan values as 
determined by using Kaplan-Meier log-rank statistical test (p<0.0001). In contrast, y, w flies do 
not show significant changes in their lifespan values. (B) Survival curves of male and female 
DJ-1βA286 mutant flies after chronic treatment with 1mM α-tocopherol. The median and 
maximum lifespan values are as follows: DJ-1βA286 males untreated 36 and 48.5 days; DJ-1βA286 
males treated 40 and 53.4 days; DJ-1βA286 females untreated 30 and 44 days; DJ-1βA286 females 
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treated 38 and 50 days. In both sexes, α-tocopherol supplementation significantly extends 
lifespan as determined by using Kaplan-Meier log-rank statistical test (p<0.0001 in both cases). 
However, females show higher increase of the lifespan values than males. 
 
Figure 6. Oxidative stress markers in y, w control flies and DJ-1βA286 mutants. (A-B) DCFH-
DA staining of whole-mount adult brains from 1-2-day-old y, w and DJ-1βA286 flies. Weak 
signals in A represent a combination of weak ROS staining and autofluorescence of adult fly 
brains. Note that loss of DJ-1β function leads to an elevation of ROS levels (compare A with 
B). (C) Increase in lipid peroxidation (LPO) product malondialdehyde (MDA) in 1-2-day old 
DJ-1βA286 mutants compared to age-matched y, w control flies (p<0.05). (D) Catalase (CAT) 
enzymatic activity is also increased in 1-2-day old DJ-1βA286 mutants compared to age-matched 
y, w control flies (p<0.001). In C and D data are expressed as mean and standard deviation of 
replicate determinations for 4 and 3 samples, respectively.  
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